Azilsartan Medoxomil
Back to searchMolecule Structure
Scientific Name
Azilsartan Medoxomil
Description of the Drug
Azilsartan medoxomil is an angiotensin II receptor blocker used to treat hypertension alone or in combination with other antihypertensive agents, such as chlorthalidone.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB08822
http://www.drugbank.ca/drugs/DB08822
Brand Name(s)
Edarbi
Company Owner(s)
Azurity Pharmaceuticals Inc, Lupin Ltd
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Type-1 angiotensin II receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL227 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL683374 | ||
Human Metabolome Database | HMDB0248803 | ||
DrugBank | DB08822 | ||
PubChem: Thomson Pharma | 16432925 | ||
PubChem | 135409642 | ||
Nikkaji | J2.748.955I | ||
EPA CompTox Dashboard | DTXSID10235482 | ||
DrugCentral | 4322 | ||
Brenda | 198475 | ||
ChemicalBook | CB32516566 | ||
Guide to Pharmacology | 6900 | ||
rxnorm | EDARBI | AZILSARTAN KAMEDOXOMIL | AZILSARTAN MEDOXOMIL |
ChEBI | 68845 | ||
ZINC | ZINC000014210642 |